Close Menu

NEW YORK (GenomeWeb) – Castle Bioscience said today that it has received a clinical laboratory permit from the New York State Department of Health, allowing the company to offer three of its PCR-based expression profile cancer tests in the state.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.